Suchen Sie nach Informationen zu Unternehmensleiter Von Teva Pharmaceuticals? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/
With his leadership positions in various healthcare corporations, including his experience as a chairman and a director of several international corporations and his service as the President and Chief Executive Officer of Teva, Mr. Schultz provides unique global perspective on the healthcare and pharmaceutical industries. Read more Richard Daniell
https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/
Chairman of the Board Independent Director. Qualifications : With his long career as a senior pharmaceutical executive and leadership roles in various biopharmaceutical companies, Dr. Barer provides broad and experienced knowledge of the global pharmaceutical business and industry as well as extensive scientific expertise. Read more.
https://en.wikipedia.org/wiki/Teva_Pharmaceuticals
https://www.tevapharm.ch/about-teva/company-profile/
Since Teva’s establishment in 1901 in Jerusalem, our leadership has been marked by tenacity, entrepreneurial spirit, and an aspiration to improve people's lives. We are excited to continue helping improve the health of generations of Teva patients for years to come. Footnotes MGA Economic Impact Study dated June 2017
Teva pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 2,400 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day.
https://www.finanzen.net/unternehmensprofil/teva
Teva Pharmaceutical Industries Ltd ist ein Unternehmen aus der Branche Pharma aus Israel. Teva Pharmaceutical Industries Aktionärsstruktur …
https://www.tevausa.com/our-products/
At Teva we believe that every one of us should have access to quality medicine that helps manage disease, fight infection, or simply improves overall health. Around 200 million people worldwide take one of our medicines every day.
https://news.feed-reader.net/194755-teva-pharmaceutical-industries.html
New York - Rating-Update: Aaron Gal, Analyst von Sanford C. Bernstein & Co, stuft die Aktie des Biotechkonzerns TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098, WKN: 883035, Ticker-Symbol: TEV, NYSE-Symbol: TEVA) von 'market perform' auf 'outperform' hoch. Das Kursziel laute 11,00 USD.
https://www.wsj.com/market-data/quotes/TEVA/company-people/executive-profile/114211307
presently, deborah a. griffin holds the position of chief accounting officer & senior vice president of teva pharmaceutical industries ltd. and co-chief executive officer, director & vp at teva...
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Unternehmensleiter Von Teva Pharmaceuticals gefunden haben.
